March 11, the east coast of Honshu, Japan, magnitude 9 earthquake off the coast. After the earthquake, the domestic A-share market hot stocks radiation, Meiluoyaoye, Lik Sang pharmaceutical, human welfare medicine, Provincetown shares of continuous rise.
However, in hot pursuit of the capital market does not mean that businesses can directly benefit, experts said,digital thermometer pharmaceutical raw materials related to the company exports to Japan after the earthquake will be some opportunities, but generally speaking,clinical thermometer the Japanese will not be affected significantly affect import and export business.
Nuclear power plant caused by the destruction of nuclear contamination scare spread to the general public, due to the existence of such expectations, after the earthquake, the concept of A-share market is capital stir radiation,ear thermometer production of drugs against nuclear radiation and the production of potassium iodide tablets Meiluoyaoye force Health and Pharmaceuticals are continuously rising. Also issued a number of brokerage research reports, to remind the market trading opportunities brought attention to radiation protection. Therefore, the Chinese Medicines and Health Products Import and Export Chamber of Commerce, said the Deputy Secretary-General Tan San mining, manufacturing enterprises radiation drug benefit first in A share market, import and export enterprises in the market,digital blood pressure monitor but no direct benefit. The reason is Japan has strict restrictions for the import agents, drugs need to enter the Japanese market through Japanese GMP certification, few listed companies have qualified to the Japanese export agents.
He said that, relatively speaking, of domestic exports to Japan have qualified APIs may be some opportunities for the company. The reason is part of the local raw material drug companies in Japan affected by the earthquake cut, the company rebuilding after the earthquake, power shortages and pollution of radioactive substances may also affect the local production of pharmaceutical raw materials, sales, and hence the business enterprise is expected to increase exports to Japan. In addition, Japan also faces the secondary disaster prevention, prevention of infectious diseases after the earthquake, the future may be a large demand for such drugs, related to the business of domestic enterprises may benefit. But usually by the international community after the disaster will be a large number of contributions, post-disaster medical relief will not have significant impact on corporate profits has brought. But Japan is still in the crisis of nuclear radiation leak, it will continue to spread nuclear contamination is an important external factors.
"In fact, a strong sense of the Japanese earthquake, the northeast part of the region is currently only individual companies are doing suspend production for rectification, other places of business not affected." Medicines & Health Products Co., Ltd. China, said Li Gang, President after the earthquake, China's health insurance company immediately sent a message of sympathy to Japanese customers letters to the overall situation, the company's Japan business remains normal, the next will not be much of an impact. "Japanese companies are strong adjustment, even if the affected plant somewhere, or you can rapidly deploy resources to other areas. So that may be affected by processing some impact, but do not show the short term. China's exports of raw materials, drugs may increase. Japan is China's major import markets medical devices, but most products have been localized, the Japanese enterprises in foreign factories are very common on the market of Japanese brands only a few key components of medical devices are manufactured in Japan, Other domestic production have been achieved. So, overall speaking, import and export trade with Japan minimal affected by the earthquake. "Gang expects the Japanese pharmaceutical industry does not export significant" earthquake. "